文献速递鼻科

非保留黏膜的内镜鼻窦手术(部分重启)治疗难治性慢性鼻窦炎伴鼻息肉:学术医院经验

Outcomes of Non-Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience.
PubMed 文献 · Laryngoscope · 2022-10-06

本研究纳入30例多次手术、不适合单克隆抗体治疗的难治性慢性鼻窦炎伴鼻息肉患者,行部分重启手术。术后复发率降低、无复发生存期延长、生活质量改善且口服糖皮质激素使用归零。作者认为仍需更大样本和更长随访评估长期疗效与安全性。

要点

  • 部分重启术后7例(23.3%)复发,平均复发时间16.67±3.07个月,术前所有患者均复发,平均复发时间8.08±2.83个月。
  • 重启术后12、18、24个月复发率均显著低于既往其他手术(P=0.010、P=0.002、P=0.016)。
  • 术前21例(70%)每年口服糖皮质激素≥2个疗程,末次随访时重启术后无患者使用任何疗程。

核心结论

  • 部分重启手术显示更低的复发率、更长的无复发生存期、改善的生活质量以及口服糖皮质激素使用归零。
  • 作者认为需要更大样本和更长随访研究来评估该手术的长期疗效和安全性。

研究设计与样本

  • 非随机回顾性队列研究,证据等级为4级(根据牛津循证医学中心2011年证据等级指南)。
  • 连续纳入30例多次手术、不适合单克隆抗体治疗的难治性慢性鼻窦炎伴鼻息肉患者,接受部分重启手术。

主要发现

  • 重启术前所有患者均出现疾病复发,平均复发时间8.08±2.83个月;重启术后7例(23.3%)复发,平均复发时间16.67±3.07个月(p=0.02)。
  • 重启术后12、18、24个月随访复发率均显著低于既往其他手术(p=0.010、p=0.002、p=0.016)。
  • 无复发生存期差异显著(log-rank检验=4.16;p=0.04)。
  • SNOT-22总分及单项评分术前与术后差异显著(p=0.001),VAS评分差异亦显著(p=0.001)。
  • 术前21例(70%)每年口服糖皮质激素≥2个疗程;末次随访时重启术后无患者使用任何疗程口服糖皮质激素。

局限性

  • 作者指出需要更大样本和更长随访研究来评估该手术的长期疗效和安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The reboot approach could be an effective treatment option to lower recurrence rates (RRs) in recalcitrant Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). The purpose of this study was to investigate RR, recurrence-free survival (RFS), quality of life (QoL) improvement, and oral corticosteroid (OCS) intake in pluri-operated CRSwNP patients treated with partial reboot surgery. METHODS: A consecutive sample of patients with recalcitrant CRSwNP, ineligible for monoclonal antibodies, underwent partial reboot surgery. The 22-item SinoNasal Outcome Test (SNOT-22), Visual Analogue Scales (VAS) scores, OCS intake, and endoscopic Nasal Polyp Score (NPS) were collected pre and postoperatively. The main outcomes were RR and RFS, and comparison of disease-free time with previous endoscopic surgeries. RESULTS: Thirty pluri-operated patients were enrolled. Before the reboot, all had experienced disease recurrence at a mean recurrence time of 8.08 ± 2.83 months after surgery. After reboot, 7 (23.3%) had recurrence at a mean time of 16.67 ± 3.07 months (p = 0.02); none needed additional revision surgery till time of data collection. RR at 12, 18, and 24 months follow-up resulted significantly lower for reboot than other previous surgeries (p = 0.010, p = 0.002, p = 0.016, respectively); RFS difference resulted significant (log-rank test = 4.16; p = 0.04). Differences between pre-and post-operative total and single-items scores of SNOT-22 were significant (p = 0.001), as well as VAS scores (p = 0.001). Before the reboot, 21 patients (70%) took ≥2 OCS courses per year; at the latest follow-up visit, none had taken any course of OCS after reboot. CONCLUSIONS: The reboot approach showed lower RR, longer RFS, improved QoL, and zeroing of OCS uptake. Larger samples and longer follow-up studies are needed to assess long-term efficacy and safety of this procedure. LEVEL OF EVIDENCE: 4: According to the Oxford Center for Evidence-Based Medicine 2011 level of evidence guidelines, this non-randomized retrospective cohort study is classified as level 4 evidence Laryngoscope, 2022. Laryngoscope, 133:1584-1589, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Pirola F, Pace GM, Giombi F, et al. Outcomes of Non-Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience. Laryngoscope. 2022. PMID: 36200712. doi:10.1002/lary.30422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。